Attached files

file filename
EX-99.1 - PRESS RELEASE - ETHEMA HEALTH Corpgrstpr1002.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 30, 2013

 

GREENESTONE HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

Colorado 000-15078 84-1227328

(State or other jurisdiction of

incorporation or organization)

(Commission File Number)

(IRS Employer

Identification No.)

 

5734 Yonge Street, Suite 300

North York, Ontario, Canada M2M 4E7

(Address of principal executive offices)

 

(416) 222-5501
(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ] Written communications pursuant to Rule 425 under the Securities Act

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

Prepared By:

 

http:||www.sec.gov|Archives|edgar|data|792935|000139160913000227|image_001.jpg

Sunny J. Barkats, Esq.

JSBarkats, PLLC

18 East 41st Street, 14th Floor

New York, NY 10017

P: (646) 502-7001

F: (646) 607-5544

www.JSBarkats.com

 
 

 

Item 1.02 Termination of a Material Definitive Agreement.

 

On April 2, 2013, GreeneStone Healthcare Corporation, a Colorado corporation (the “Company”), entered into a Securities Purchase Agreement (the “Agreement”) with Asher Enterprises, Inc., a Delaware corporation (the “Investor”), pursuant to which the Company sold to the Investor a convertible note in the principal amount of $108,500, bearing interest at the rate of 8% per annum (the “Convertible Note”) (see the Company’s Current Report on Form 8-K filed on April 3, 2013).

 

On September 30, 2013, the Company paid-off the full amount owed to the Investor under the Convertible Note, including the principal balance and any and all accrued interest and pre-payment penalties (the “Payment”). Upon the Payment, and in accordance with the terms of the Agreement and the Convertible Note, the Agreement was terminated and the Convertible Note cancelled and returned to the Company.

 

Item 8.01 Other Events.

 

On October 2, 2013, the Company issued a press release disclosing the discharge of debt related to the Payment of the Convertible Note. A copy of the press release is attached as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Document
     
99.1   Press Release

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

      GREENESTONE HEALTHCARE CORPORATION
           
           
Date: October 2, 2013   By: /s/ Shawn E. Leon  
        Name: Shawn E. Leon  
        Title: Chief Executive Officer